Businesswire·2026-01-09 14:05Core Insights - Amazon Pharmacy has begun offering Novo Nordisk's newly FDA-approved oral GLP-1 medication, enhancing its pharmaceutical product range [1] - The service includes transparent pricing and fast, free home delivery, which aligns with Amazon's strategy to improve customer convenience in healthcare [1] Company Summary - Amazon Pharmacy is expanding its offerings by including Novo Nordisk's oral GLP-1, indicating a focus on chronic disease management and diabetes care [1] - The introduction of transparent pricing is a significant move towards increasing price visibility for consumers, which is a growing trend in the pharmaceutical industry [1] - Fast and free home delivery services are part of Amazon's broader strategy to leverage its logistics capabilities in the healthcare sector [1]